Halozyme Therapeutics, Inc. (HALO): Revenue
$1.40B
Year ended 2025-12-31
$1.66B
Trailing 12 months to 2026-06-30
+28.4%
3-year compound annual growth
+39.2%
5-year compound annual growth
+26.3%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.40B | +37.6% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $1.02B | +22.4% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $829.25M | +25.6% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $660.12M | +48.9% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | $443.31M | +65.7% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $267.59M | +36.5% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $195.99M | +29.1% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $151.86M | -52.0% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $316.61M | +115.8% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $146.69M | +8.6% | 2019-02-21, From 2016-01-01 |
| 2015-12-31 | $135.06M | +79.3% | 2018-02-20, From 2015-01-01 |
| 2014-12-31 | $75.33M | +37.5% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $54.80M | +29.5% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $42.33M | -24.5% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $56.09M | +311.7% | 2014-02-28, From 2011-01-01 |
| 2010-12-31 | $13.62M | -0.3% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $13.67M | n/a | 2012-03-12, From 2009-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $1.40B | +37.6% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $1.22B | -0.4% |
| Novavax Inc (NVAX) | 2025-12-31 | $1.12B | +64.7% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $1.94B | -39.9% |
| Qiagen N.V. (QGEN) | 2025-12-31 | $2.09B | +5.7% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $874.84M | +94.1% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $2.32B | +7.0% |
| Repligen Corp (RGEN) | 2025-12-31 | $738.26M | +16.4% |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $2.86B | +21.4% |
Compare HALO, TECH, NVAX, MRNA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗